ZINOLI, LINDA
 Distribuzione geografica
Continente #
EU - Europa 1.754
Totale 1.754
Nazione #
IT - Italia 1.754
Totale 1.754
Città #
Genova 1.075
Genoa 298
Rapallo 279
Vado Ligure 97
Bordighera 5
Totale 1.754
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 153
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 117
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa) 113
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 110
Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer? 109
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death 103
Prognostic value of nuclear matrix protein expression in localized prostate cancer. 102
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 102
68P * Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes 95
Immunohistochemical detection of FMRFamide-related peptides in a primitive nervous system 89
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 84
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 80
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 80
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 76
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS) 70
THE PROGNOSTIC VALUE OF PERIOSTIN EXPRESSION IN HUMAN PROSTATE CANCER 62
Prognostic value of Periostin expression in human prostate cancer 53
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 53
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer 48
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review 38
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives 30
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 25
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 23
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer 14
Totale 1.829
Categoria #
all - tutte 6.829
article - articoli 6.599
book - libri 0
conference - conferenze 230
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020475 0 0 0 23 85 73 69 37 39 80 53 16
2020/2021190 7 16 11 44 7 10 2 25 12 29 8 19
2021/2022263 2 13 14 25 18 24 5 58 18 28 24 34
2022/2023317 18 37 7 23 69 46 0 30 46 1 37 3
2023/2024254 5 21 10 25 24 46 19 10 7 27 11 49
2024/2025114 31 38 33 12 0 0 0 0 0 0 0 0
Totale 1.829